UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 156

Sortiert nach

Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study

PloS one, 2023-04, Vol.18 (4), p.e0282633-e0282633

2023

Volltextzugriff (PDF)

In vitro effects of a novel hemoglobin-based oxygen carrier on routine chemistry, therapeutic drug, coagulation, hematology, and blood bank assays

Clinical chemistry (Baltimore, Md.), 1997-09, Vol.43 (9), p.1744-1748

1997

Volltextzugriff (PDF)

Tissue factor antigen levels in various biological fluids

Blood coagulation & fibrinolysis, 1995-06, Vol.6 Sup 1 (Sup 1), p.S32-S36

1995

Volltextzugriff (PDF)

Comparative pharmacology of site directed antithrombin agents. Implication in drug development

Thrombosis and haemostasis, 1995-07, Vol.74 (1), p.473

1995

Volltextzugriff (PDF)

Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time method

Thrombosis research, 1996-09, Vol.83 (6), p.463-468

1996

Volltextzugriff (PDF)

Evidence of myocardial infarction in mummified human tissue

JAMA : the journal of the American Medical Association, 2000-08, Vol.284 (7), p.831

2000

Volltextzugriff (PDF)

Antithrombin Agents: The New Class of Anticoagulant and Antithrombotic Drugs

Clinical and applied thrombosis/hemostasis, 1999-10, Vol.5 (1_suppl), p.S45-S55

1999

Volltextzugriff (PDF)

Direct inhibition of protein Ca by site directed thrombin inhibitors: Implications in anticoagulant and thrombolytic therapy

Thrombosis research, 1995-06, Vol.78 (5), p.457-460

1995

Volltextzugriff (PDF)

Comparative studies on the antithrombin potency of various thrombin inhibitors, as determined by using an amidolytic method

Thrombosis research, 1996-07, Vol.83 (1), p.97-102

1996

Volltextzugriff (PDF)

Antithrombin agents as anticoagulants and antithrombotics : Implications in drug development

Seminars in hematology, 1999, Vol.36 (1), p.42-56

1999

Volltextzugriff (PDF)

Synthetic and recombinant antithrombin drugs

Expert opinion on investigational drugs, 1998-06, Vol.7 (6), p.963-985

1998

Volltextzugriff (PDF)

Antithrombin agents as anticoagulants and antithrombotics. Implications in drug development

The Medical clinics of North America, 1998-05, Vol.82 (3), p.569-586

1998

Volltextzugriff (PDF)

Studies on the thrombogenic effects of recombinant tissue factor. In vivo versus ex vivo findings

Seminars in thrombosis and hemostasis, 1995, Vol.21 (2), p.166

1995

Volltextzugriff (PDF)

Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin

Seminars in thrombosis and hemostasis, 1995, Vol.21 (2), p.177-183

1995

Volltextzugriff (PDF)

Molecular weight and biochemical profile of a chemically modified heparin derivative, Suleparoide

Thrombosis research, 1993-02, Vol.69 (4), p.369-376

1993

Volltextzugriff (PDF)

Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systems

Thrombosis research, 1994-03, Vol.73 (5), p.327-335

1994

Volltextzugriff (PDF)

Comparison of the Anticoagulant Activities of Thrombin Inhibitors as Assessed by Thromboelastographic Analysis

Seminars in thrombosis and hemostasis, 1995-01, Vol.21 (S 04), p.076-079

1995

Volltextzugriff (PDF)

Comparative pharmacologic profile of a glycosaminoglycan mixture, sulodexide, and a chemically modified heparin derivative, suleparoide

Seminars in thrombosis and hemostasis, 1993, Vol.19, p.49-57

1993

Volltextzugriff (PDF)

The thrombolytic potency of LMW-heparin compared to urokinase in a rabbit jugular vein clot lysis model

Thrombosis research, 1992-05, Vol.66 (2), p.151-158

1992

Volltextzugriff (PDF)

Fibrinolytic Compromise by Synthetic and Recombinant Thrombin Inhibitors: Implications in the Treatment of Thrombotic Disorders

Clinical and applied thrombosis/hemostasis, 1995-03, Vol.1 (2), p.114-124

1995

Volltextzugriff (PDF)

Antithrombin III Affinity Dependence on the Anticoagulant, Antiprotease, and Tissue Factor Pathway Inhibitor Actions of Heparins

Seminars in thrombosis and hemostasis, 1995-01, Vol.21 (2), p.193-200

1995

Volltextzugriff (PDF)

Comparative intravenous antithrombotic actions of heparin and site directed thrombin inhibitors in a jugular vein clamping model

Thrombosis research, 1996-04, Vol.82 (2), p.187-191

1996

Volltextzugriff (PDF)

Section Review-Cardiovascular & Renal: Recent Developments in Antithrombotic Agents

Expert opinion on investigational drugs, 1995-05, Vol.4 (5), p.389-412

1995

Volltextzugriff (PDF)

Selectins in the HIT syndrome: pathophysiologic role and therapeutic modulation

Seminars in thrombosis and hemostasis, 1999, Vol.25 Suppl 1, p.37

1999

Volltextzugriff (PDF)

Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs : Efegatran®, argatroban, hirulog, and hirudin: Frontiers in vascular medicine

Seminars in thrombosis and hemostasis, 1995, Vol.21 (2), p.177-183

1995

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(139)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Life Sciences & Biomedicine
(66)
Humans
(52)
Biological And Medical Sciences
(37)
Medical Sciences
(33)
Cardiovascular System & Cardiology
(29)
Hematology
(28)
Peripheral Vascular Disease
(27)
Male
(25)
Female
(22)
Pharmacology. Drug Treatments
(16)
Physical Sciences
(16)
Middle Aged
(15)
Blood. Blood Coagulation. Reticuloendothelial System
(14)
Physics
(14)
Adult
(13)
Aged
(13)
Animals
(12)
Risk Factors
(12)
Antithrombins - Pharmacology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study

In vitro effects of a novel hemoglobin-based oxygen carrier on routine chemistry, therapeutic drug, coagulation, hematology, and blood bank assays

Tissue factor antigen levels in various biological fluids

Comparative pharmacology of site directed antithrombin agents. Implication in drug development

Comparative anticoagulant effects of various thrombin inhibitors, as determined in the ecarin clotting time method

Evidence of myocardial infarction in mummified human tissue

Antithrombin Agents: The New Class of Anticoagulant and Antithrombotic Drugs

Direct inhibition of protein Ca by site directed thrombin inhibitors: Implications in anticoagulant and thrombolytic therapy

Comparative studies on the antithrombin potency of various thrombin inhibitors, as determined by using an amidolytic method

Antithrombin agents as anticoagulants and antithrombotics : Implications in drug development

Synthetic and recombinant antithrombin drugs

Antithrombin agents as anticoagulants and antithrombotics. Implications in drug development

Studies on the thrombogenic effects of recombinant tissue factor. In vivo versus ex vivo findings

Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin

Molecular weight and biochemical profile of a chemically modified heparin derivative, Suleparoide

Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systems

Comparison of the Anticoagulant Activities of Thrombin Inhibitors as Assessed by Thromboelastographic Analysis

Comparative pharmacologic profile of a glycosaminoglycan mixture, sulodexide, and a chemically modified heparin derivative, suleparoide

The thrombolytic potency of LMW-heparin compared to urokinase in a rabbit jugular vein clot lysis model

Fibrinolytic Compromise by Synthetic and Recombinant Thrombin Inhibitors: Implications in the Treatment of Thrombotic Disorders

Antithrombin III Affinity Dependence on the Anticoagulant, Antiprotease, and Tissue Factor Pathway Inhibitor Actions of Heparins

Comparative intravenous antithrombotic actions of heparin and site directed thrombin inhibitors in a jugular vein clamping model

Section Review-Cardiovascular & Renal: Recent Developments in Antithrombotic Agents

Selectins in the HIT syndrome: pathophysiologic role and therapeutic modulation

Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs : Efegatran®, argatroban, hirulog, and hirudin: Frontiers in vascular medicine

Suchergebnisse filtern